ArticleCureus2026

Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System.

Abhinandan Singla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.